|  Help  |  About  |  Contact Us

Search our database by keyword

Examples

  • Search this entire website. Enter identifiers, names or keywords for genes, diseases, strains, ontology terms, etc. (e.g. Pax6, Parkinson, ataxia)
  • Use OR to search for either of two terms (e.g. OR mus) or quotation marks to search for phrases (e.g. "dna binding").
  • Boolean search syntax is supported: e.g. Balb* for partial matches or mus AND NOT embryo to exclude a term

Search results 101 to 200 out of 454 for Pbsn

<< First    < Previous  |  Next >    Last >>
0.03s

Categories

Hits by Category

Hits by Strain

Type Details Score
Publication
19690330 | J:260259
First Author: Chen Z
Year: 2009
Journal: Sci Signal
Title: Differential p53-independent outcomes of p19(Arf) loss in oncogenesis.
Volume: 2
Issue: 84
Pages: ra44
•
•
•
•
•
Publication
16912162 | J:112104
First Author: Zhou Z
Year: 2006
Journal: Cancer Res
Title: Synergy of p53 and Rb deficiency in a conditional mouse model for metastatic prostate cancer.
Volume: 66
Issue: 16
Pages: 7889-98
•
•
•
•
•
Publication
21289624 | J:262076
First Author: Ding Z
Year: 2011
Journal: Nature
Title: SMAD4-dependent barrier constrains prostate cancer growth and metastatic progression.
Volume: 470
Issue: 7333
Pages: 269-73
•
•
•
•
•
Publication
20585617 | J:161511
First Author: Francis JC
Year: 2010
Journal: PLoS Genet
Title: Brca2 and Trp53 deficiency cooperate in the progression of mouse prostate tumourigenesis.
Volume: 6
Issue: 6
Pages: e1000995
•
•
•
•
•
Strain
MGI:5607250 | STOCK Akap12<tm1Ihg> Rb1<tm2Brn> Tg(Pbsn-cre)4Prb/J
Attribute String: transgenic, targeted mutation, mutant stock
•
•
•
•
•
Publication
24492704 | J:209148
First Author: Ko HK
Year: 2014
Journal: Cancer Res
Title: A transgenic mouse model for early prostate metastasis to lymph nodes.
Volume: 74
Issue: 3
Pages: 945-53
•
•
•
•
•
Publication
37587334 | J:341105
First Author: Buñay J
Year: 2023
Journal: Oncogene
Title: Persistent organic pollutants promote aggressiveness in prostate cancer.
Volume: 42
Issue: 38
Pages: 2854-2867
•
•
•
•
•
Publication
37644036 | J:341119
First Author: Rasool RU
Year: 2023
Journal: Nat Commun
Title: Loss of LCMT1 and biased protein phosphatase 2A heterotrimerization drive prostate cancer progression and therapy resistance.
Volume: 14
Issue: 1
Pages: 5253
•
•
•
•
•
Publication
32341756 | J:310974
First Author: Antoch MP
Year: 2020
Journal: Oncotarget
Title: Superior cancer preventive efficacy of low versus high dose of mTOR inhibitor in a mouse model of prostate cancer.
Volume: 11
Issue: 15
Pages: 1373-1387
•
•
•
•
•
Publication
38654106 | J:350279
First Author: Francis JC
Year: 2024
Journal: Oncogene
Title: Identification of genes that promote PI3K pathway activation and prostate tumour formation.
Volume: 43
Issue: 24
Pages: 1824-1835
•
•
•
•
•
Publication
22279083 | J:181487
First Author: Ting MC
Year: 2012
Journal: Dis Model Mech
Title: An enhancer from the 8q24 prostate cancer risk region is sufficient to direct reporter gene expression to a subset of prostate stem-like epithelial cells in transgenic mice.
Volume: 5
Issue: 3
Pages: 366-74
•
•
•
•
•
Publication
28350865 | J:246983
First Author: Le B
Year: 2017
Journal: PLoS One
Title: Multi-drug loaded micelles delivering chemotherapy and targeted therapies directed against HSP90 and the PI3K/AKT/mTOR pathway in prostate cancer.
Volume: 12
Issue: 3
Pages: e0174658
•
•
•
•
•
Publication
16432235 | J:105995
First Author: Wang S
Year: 2006
Journal: Proc Natl Acad Sci U S A
Title: Pten deletion leads to the expansion of a prostatic stem/progenitor cell subpopulation and tumor initiation.
Volume: 103
Issue: 5
Pages: 1480-5
•
•
•
•
•
Publication
29484136 | J:309123
First Author: Francis JC
Year: 2018
Journal: Oncotarget
Title: SOX9 is a driver of aggressive prostate cancer by promoting invasion, cell fate and cytoskeleton alterations and epithelial to mesenchymal transition.
Volume: 9
Issue: 7
Pages: 7604-7615
•
•
•
•
•
Publication
22374980 | J:185631
First Author: Tang S
Year: 2012
Journal: Cancer Res
Title: Increased CD8+ T-cell function following castration and immunization is countered by parallel expansion of regulatory T cells.
Volume: 72
Issue: 8
Pages: 1975-85
•
•
•
•
•
Publication
22367541 | J:183775
First Author: Hsieh AC
Year: 2012
Journal: Nature
Title: The translational landscape of mTOR signalling steers cancer initiation and metastasis.
Volume: 485
Issue: 7396
Pages: 55-61
•
•
•
•
•
Publication
28512253 | J:245814
First Author: Lerman I
Year: 2017
Journal: Mol Cancer Res
Title: Infiltrating Myeloid Cells Exert Protumorigenic Actions via Neutrophil Elastase.
Volume: 15
Issue: 9
Pages: 1138-1152
•
•
•
•
•
Publication
14522255 | J:93902
First Author: Wang S
Year: 2003
Journal: Cancer Cell
Title: Prostate-specific deletion of the murine Pten tumor suppressor gene leads to metastatic prostate cancer.
Volume: 4
Issue: 3
Pages: 209-21
•
•
•
•
•
Publication
22209699 | J:181962
First Author: Conley-LaComb MK
Year: 2012
Journal: Am J Pathol
Title: PTEN regulates PDGF ligand switch for β-PDGFR signaling in prostate cancer.
Volume: 180
Issue: 3
Pages: 1017-27
•
•
•
•
•
Publication
20406970 | J:159457
First Author: Akins EJ
Year: 2010
Journal: Cancer Res
Title: In situ vaccination combined with androgen ablation and regulatory T-cell depletion reduces castration-resistant tumor burden in prostate-specific pten knockout mice.
Volume: 70
Issue: 9
Pages: 3473-82
•
•
•
•
•
Publication
19326431 | J:151360
First Author: Narayanan NK
Year: 2009
Journal: Int J Cancer
Title: Liposome encapsulation of curcumin and resveratrol in combination reduces prostate cancer incidence in PTEN knockout mice.
Volume: 125
Issue: 1
Pages: 1-8
•
•
•
•
•
Publication
25544636 | J:218824
First Author: Schwartz S
Year: 2015
Journal: Cancer Cell
Title: Feedback suppression of PI3Kα signaling in PTEN-mutated tumors is relieved by selective inhibition of PI3Kβ.
Volume: 27
Issue: 1
Pages: 109-22
•
•
•
•
•
Publication
31914691 | J:291962
First Author: Wang C
Year: 2020
Journal: FASEB J
Title: PTEN deletion drives aberrations of DNA methylome and transcriptome in different stages of prostate cancer.
Volume: 34
Issue: 1
Pages: 1304-1318
•
•
•
•
•
Publication
16055444 | J:106938
First Author: Berquin IM
Year: 2005
Journal: J Biol Chem
Title: Expression signature of the mouse prostate.
Volume: 280
Issue: 43
Pages: 36442-51
•
•
•
•
•
Publication
36551505 | J:332248
 
First Author: Krolewski JJ
Year: 2022
Journal: Cancers (Basel)
Title: TNF Signaling Is Required for Castration-Induced Vascular Damage Preceding Prostate Cancer Regression.
Volume: 14
Issue: 24
•
•
•
•
•
Publication
30610107 | J:273249
First Author: Lerman I
Year: 2019
Journal: Mol Cancer Res
Title: Epigenetic Suppression of SERPINB1 Promotes Inflammation-Mediated Prostate Cancer Progression.
Volume: 17
Issue: 4
Pages: 845-859
•
•
•
•
•
Publication
32162714 | J:333087
First Author: Zhang J
Year: 2020
Journal: Prostate
Title: Proteomic and transcriptomic profiling of Pten gene-knockout mouse model of prostate cancer.
Volume: 80
Issue: 7
Pages: 588-605
•
•
•
•
•
Publication
26563471 | J:251220
 
First Author: Hu X
Year: 2015
Journal: Sci Rep
Title: Inhibition of Pten deficient Castration Resistant Prostate Cancer by Targeting of the SET - PP2A Signaling axis.
Volume: 5
Pages: 15182
•
•
•
•
•
Publication
28489892 | J:248322
First Author: Okeyo-Owuor T
Year: 2017
Journal: PLoS One
Title: Exposure to maternal obesogenic diet worsens some but not all pre-cancer phenotypes in a murine genetic model of prostate cancer.
Volume: 12
Issue: 5
Pages: e0175764
•
•
•
•
•
Publication
34662447 | J:332941
First Author: Kim S
Year: 2022
Journal: Prostate
Title: Aqueous metabolome of tissue-specific conditional Pten-knockout mouse prostate cancer and TRAMP neuroendocrine carcinoma.
Volume: 82
Issue: 1
Pages: 154-166
•
•
•
•
•
Publication
22777769 | J:193157
First Author: Goel HL
Year: 2012
Journal: Cancer Discov
Title: VEGF/neuropilin-2 regulation of Bmi-1 and consequent repression of IGF-IR define a novel mechanism of aggressive prostate cancer.
Volume: 2
Issue: 10
Pages: 906-21
•
•
•
•
•
Publication
24662052 | J:215359
First Author: Garcia AJ
Year: 2014
Journal: Mol Cell Biol
Title: Pten null prostate epithelium promotes localized myeloid-derived suppressor cell expansion and immune suppression during tumor initiation and progression.
Volume: 34
Issue: 11
Pages: 2017-28
•
•
•
•
•
Publication
32078585 | J:301216
 
First Author: Pan C
Year: 2020
Journal: JCI Insight
Title: Prostate tumor-derived GDF11 accelerates androgen deprivation therapy-induced sarcopenia.
Volume: 5
Issue: 6
•
•
•
•
•
Publication
29795142 | J:286961
First Author: Allott EH
Year: 2018
Journal: Prostate Cancer Prostatic Dis
Title: Serum cholesterol levels and tumor growth in a PTEN-null transgenic mouse model of prostate cancer.
Volume: 21
Issue: 2
Pages: 196-203
•
•
•
•
•
Publication
19738074 | J:152681
First Author: Zhang W
Year: 2009
Journal: Cancer Res
Title: Inhibition of tumor growth progression by antiandrogens and mTOR inhibitor in a Pten-deficient mouse model of prostate cancer.
Volume: 69
Issue: 18
Pages: 7466-72
•
•
•
•
•
Publication
25176644 | J:314624
First Author: Wang L
Year: 2014
Journal: Cell Rep
Title: Hexokinase 2-mediated Warburg effect is required for PTEN- and p53-deficiency-driven prostate cancer growth.
Volume: 8
Issue: 5
Pages: 1461-74
•
•
•
•
•
Publication
23817021 | J:200002
First Author: Chen Y
Year: 2013
Journal: Nat Med
Title: ETS factors reprogram the androgen receptor cistrome and prime prostate tumorigenesis in response to PTEN loss.
Volume: 19
Issue: 8
Pages: 1023-9
•
•
•
•
•
Publication
28292441 | J:239660
First Author: Blattner M
Year: 2017
Journal: Cancer Cell
Title: SPOP Mutation Drives Prostate Tumorigenesis In Vivo through Coordinate Regulation of PI3K/mTOR and AR Signaling.
Volume: 31
Issue: 3
Pages: 436-451
•
•
•
•
•
Publication
21795710 | J:234601
First Author: Zhu C
Year: 2011
Journal: J Biol Chem
Title: Conditional expression of the androgen receptor induces oncogenic transformation of the mouse prostate.
Volume: 286
Issue: 38
Pages: 33478-88
•
•
•
•
•
Publication
16912182 | J:112108
First Author: Dai B
Year: 2006
Journal: Cancer Res
Title: Tyrosine kinase Etk/BMX is up-regulated in human prostate cancer and its overexpression induces prostate intraepithelial neoplasia in mouse.
Volume: 66
Issue: 16
Pages: 8058-64
•
•
•
•
•
Publication
20145134 | J:157607
First Author: Moussavi M
Year: 2010
Journal: Cancer Res
Title: Oncolysis of prostate cancers induced by vesicular stomatitis virus in PTEN knockout mice.
Volume: 70
Issue: 4
Pages: 1367-76
•
•
•
•
•
Publication
34547241 | J:315701
First Author: Igelmann S
Year: 2021
Journal: Mol Cell
Title: A hydride transfer complex reprograms NAD metabolism and bypasses senescence.
Volume: 81
Issue: 18
Pages: 3848-3865.e19
•
•
•
•
•
Publication
12183441 | J:78553
First Author: Huang J
Year: 2002
Journal: Cancer Res
Title: Prostatic intraepithelial neoplasia in mice with conditional disruption of the retinoid X receptor alpha allele in the prostate epithelium.
Volume: 62
Issue: 16
Pages: 4812-9
•
•
•
•
•
Publication
22314496 | J:320820
First Author: Mao GE
Year: 2012
Journal: Prostate
Title: A joint effect of new Western diet and retinoid X receptor α prostate-specific knockout with development of high-grade prostatic intraepithelial neoplasia in mice--a preliminary study.
Volume: 72
Issue: 10
Pages: 1052-9
•
•
•
•
•
Strain
MGI:6694950 | B6(Cg)-Eaf1<tm1.1Zhow> Tg(Pbsn-cre)4Prb
Attribute String: mutant strain, targeted mutation, transgenic
•
•
•
•
•
Publication
36724278 | J:333111
First Author: Triscott J
Year: 2023
Journal: Sci Adv
Title: PI5P4Kα supports prostate cancer metabolism and exposes a survival vulnerability during androgen receptor inhibition.
Volume: 9
Issue: 5
Pages: eade8641
•
•
•
•
•
Publication
29386573 | J:260198
First Author: Sengiku A
Year: 2018
Journal: Sci Rep
Title: Circadian coordination of ATP release in the urothelium via connexin43 hemichannels.
Volume: 8
Issue: 1
Pages: 1996
•
•
•
•
•
Publication
19800578 | J:153706
First Author: Wang L
Year: 2009
Journal: Cancer Cell
Title: Somatic single hits inactivate the X-linked tumor suppressor FOXP3 in the prostate.
Volume: 16
Issue: 4
Pages: 336-46
•
•
•
•
•
Publication
33245716 | J:310569
First Author: Liu B
Year: 2020
Journal: Oncotarget
Title: Evidence for context-dependent functions of KDM5B in prostate development and prostate cancer.
Volume: 11
Issue: 46
Pages: 4243-4252
•
•
•
•
•
Publication
37055829 | J:334748
First Author: Alvarez-Arzola R
Year: 2023
Journal: Cell Commun Signal
Title: VSSP-activated macrophages mediate senescence and tumor inhibition in a preclinical model of advanced prostate cancer.
Volume: 21
Issue: 1
Pages: 76
•
•
•
•
•
Publication
16820097 | J:114903
First Author: Kelavkar UP
Year: 2006
Journal: Neoplasia
Title: Conditional expression of human 15-lipoxygenase-1 in mouse prostate induces prostatic intraepithelial neoplasia: the FLiMP mouse model.
Volume: 8
Issue: 6
Pages: 510-22
•
•
•
•
•
Publication
23755247 | J:206639
First Author: Xing C
Year: 2013
Journal: PLoS One
Title: Different expression patterns and functions of acetylated and unacetylated Klf5 in the proliferation and differentiation of prostatic epithelial cells.
Volume: 8
Issue: 6
Pages: e65538
•
•
•
•
•
Publication
23428429 | J:198151
First Author: Nguyen AH
Year: 2013
Journal: Hum Mol Genet
Title: Gata3 antagonizes cancer progression in Pten-deficient prostates.
Volume: 22
Issue: 12
Pages: 2400-10
•
•
•
•
•
Publication
23727861 | J:203214
First Author: Wang G
Year: 2013
Journal: Nat Genet
Title: Zbtb7a suppresses prostate cancer through repression of a Sox9-dependent pathway for cellular senescence bypass and tumor invasion.
Volume: 45
Issue: 7
Pages: 739-746
•
•
•
•
•
Publication
23727860 | J:203215
First Author: Lunardi A
Year: 2013
Journal: Nat Genet
Title: A co-clinical approach identifies mechanisms and potential therapies for androgen deprivation resistance in prostate cancer.
Volume: 45
Issue: 7
Pages: 747-55
•
•
•
•
•
Publication
34496233 | J:320671
First Author: Grbesa I
Year: 2021
Journal: Cell Rep
Title: Reshaping of the androgen-driven chromatin landscape in normal prostate cells by early cancer drivers and effect on therapeutic sensitivity.
Volume: 36
Issue: 10
Pages: 109625
•
•
•
•
•
Publication
24866151 | J:217845
First Author: González-Billalabeitia E
Year: 2014
Journal: Cancer Discov
Title: Vulnerabilities of PTEN-TP53-deficient prostate cancers to compound PARP-PI3K inhibition.
Volume: 4
Issue: 8
Pages: 896-904
•
•
•
•
•
Publication
23845440 | J:199223
First Author: Karantanos T
Year: 2013
Journal: Cancer Cell
Title: GEMMs shine a light on resistance to androgen deprivation therapy for prostate cancer.
Volume: 24
Issue: 1
Pages: 11-3
•
•
•
•
•
Publication
33284790 | J:300165
First Author: Bousset L
Year: 2020
Journal: PLoS Biol
Title: Absence of nuclear receptors LXRs impairs immune response to androgen deprivation and leads to prostate neoplasia.
Volume: 18
Issue: 12
Pages: e3000948
•
•
•
•
•
Publication
16079851 | J:100683
First Author: Chen Z
Year: 2005
Journal: Nature
Title: Crucial role of p53-dependent cellular senescence in suppression of Pten-deficient tumorigenesis.
Volume: 436
Issue: 7051
Pages: 725-30
•
•
•
•
•
Publication
29202479 | J:258828
First Author: Shoag J
Year: 2018
Journal: J Clin Invest
Title: SPOP mutation drives prostate neoplasia without stabilizing oncogenic transcription factor ERG.
Volume: 128
Issue: 1
Pages: 381-386
•
•
•
•
•
Publication
27728805 | J:236713
First Author: Dardenne E
Year: 2016
Journal: Cancer Cell
Title: N-Myc Induces an EZH2-Mediated Transcriptional Program Driving Neuroendocrine Prostate Cancer.
Volume: 30
Issue: 4
Pages: 563-577
•
•
•
•
•
Publication
28870994 | J:301844
First Author: Pascal LE
Year: 2017
Journal: J Endocrinol
Title: Conditional deletion of ELL2 induces murine prostate intraepithelial neoplasia.
Volume: 235
Issue: 2
Pages: 123-136
•
•
•
•
•
Publication
31277777 | J:309459
First Author: Shinde D
Year: 2019
Journal: Eur Urol Oncol
Title: Transcriptional Reprogramming and Inhibition of Tumor-propagating Stem-like Cells by EC-8042 in ERG-positive Prostate Cancer.
Volume: 2
Issue: 4
Pages: 415-424
•
•
•
•
•
Publication
35393570 | J:349055
First Author: Fang L
Year: 2022
Journal: Cancer Gene Ther
Title: TMPRSS2-ERG promotes the initiation of prostate cancer by suppressing oncogene-induced senescence.
Volume: 29
Issue: 10
Pages: 1463-1476
•
•
•
•
•
Publication
30333152 | J:271158
First Author: Elfandy H
Year: 2019
Journal: Mol Cancer Res
Title: Genetic and Epigenetic Determinants of Aggressiveness in Cribriform Carcinoma of the Prostate.
Volume: 17
Issue: 2
Pages: 446-456
•
•
•
•
•
Publication
19176516 | J:261276
First Author: Nardella C
Year: 2009
Journal: Sci Signal
Title: Differential requirement of mTOR in postmitotic tissues and tumorigenesis.
Volume: 2
Issue: 55
Pages: ra2
•
•
•
•
•
Publication
28274958 | J:243131
First Author: Patnaik A
Year: 2017
Journal: Cancer Discov
Title: Cabozantinib Eradicates Advanced Murine Prostate Cancer by Activating Antitumor Innate Immunity.
Volume: 7
Issue: 7
Pages: 750-765
•
•
•
•
•
Publication
31674011 | J:285566
First Author: Wegner KA
Year: 2020
Journal: J Pathol
Title: Prostate epithelial-specific expression of activated PI3K drives stromal collagen production and accumulation.
Volume: 250
Issue: 2
Pages: 231-242
•
•
•
•
•
Publication
29335545 | J:260988
First Author: Chen M
Year: 2018
Journal: Nat Genet
Title: An aberrant SREBP-dependent lipogenic program promotes metastatic prostate cancer.
Volume: 50
Issue: 2
Pages: 206-218
•
•
•
•
•
Publication
28807943 | J:245648
First Author: Bainor AJ
Year: 2017
Journal: Cancer Res
Title: Chromatin-Associated Protein SIN3B Prevents Prostate Cancer Progression by Inducing Senescence.
Volume: 77
Issue: 19
Pages: 5339-5348
•
•
•
•
•
Publication
29187400 | J:256311
First Author: MartĂ­n-MartĂ­n N
Year: 2018
Journal: Cancer Res
Title: PPARδ Elicits Ligand-Independent Repression of Trefoil Factor Family to Limit Prostate Cancer Growth.
Volume: 78
Issue: 2
Pages: 399-409
•
•
•
•
•
Publication
25189881 | J:312333
First Author: Wiles WG 4th
Year: 2014
Journal: In Vivo
Title: Mutation of murine Sox4 untranslated regions results in partially penetrant perinatal lethality.
Volume: 28
Issue: 5
Pages: 709-18
•
•
•
•
•
Publication
25712341 | J:220160
First Author: Liu R
Year: 2015
Journal: Cancer Res
Title: FOXP3-miR-146-NF-ÎşB Axis and Therapy for Precancerous Lesions in Prostate.
Volume: 75
Issue: 8
Pages: 1714-24
•
•
•
•
•
Publication
31229879 | J:288972
First Author: Pascal LE
Year: 2019
Journal: Neoplasia
Title: Conditional Deletion of Eaf1 Induces Murine Prostatic Intraepithelial Neoplasia in Mice.
Volume: 21
Issue: 8
Pages: 752-764
•
•
•
•
•
Publication
20517984 | J:168861
First Author: Zhang L
Year: 2010
Journal: Stem Cells
Title: Dicer ablation impairs prostate stem cell activity and causes prostate atrophy.
Volume: 28
Issue: 7
Pages: 1260-9
•
•
•
•
•
Publication
33500545 | J:306413
First Author: Albino D
Year: 2021
Journal: Commun Biol
Title: Circulating extracellular vesicles release oncogenic miR-424 in experimental models and patients with aggressive prostate cancer.
Volume: 4
Issue: 1
Pages: 119
•
•
•
•
•
Publication
29950727 | J:265287
First Author: Calcinotto A
Year: 2018
Journal: Nature
Title: IL-23 secreted by myeloid cells drives castration-resistant prostate cancer.
Volume: 559
Issue: 7714
Pages: 363-369
•
•
•
•
•
Publication
23552839 | J:232842
 
First Author: Xiong X
Year: 2012
Journal: Oncogenesis
Title: Disruption of Abi1/Hssh3bp1 expression induces prostatic intraepithelial neoplasia in the conditional Abi1/Hssh3bp1 KO mice.
Volume: 1
Pages: e26
•
•
•
•
•
Publication
29121168 | J:257858
First Author: Wang H
Year: 2018
Journal: Carcinogenesis
Title: δ-Tocopherol inhibits the development of prostate adenocarcinoma in prostate specific Pten-/- mice.
Volume: 39
Issue: 2
Pages: 158-169
•
•
•
•
•
Publication
29142193 | J:338791
First Author: Wozniak DJ
Year: 2017
Journal: Nat Commun
Title: PTEN is a protein phosphatase that targets active PTK6 and inhibits PTK6 oncogenic signaling in prostate cancer.
Volume: 8
Issue: 1
Pages: 1508
•
•
•
•
•
Publication
24934715 | J:314602
First Author: Sun X
Year: 2014
Journal: Neoplasia
Title: Deletion of atbf1/zfhx3 in mouse prostate causes neoplastic lesions, likely by attenuation of membrane and secretory proteins and multiple signaling pathways.
Volume: 16
Issue: 5
Pages: 377-89
•
•
•
•
•
Publication
32219437 | J:289861
 
First Author: Hermanova I
Year: 2020
Journal: J Exp Med
Title: Genetic manipulation of LKB1 elicits lethal metastatic prostate cancer.
Volume: 217
Issue: 6
•
•
•
•
•
Publication
34230470 | J:307918
First Author: Zoma M
Year: 2021
Journal: Nat Commun
Title: EZH2-induced lysine K362 methylation enhances TMPRSS2-ERG oncogenic activity in prostate cancer.
Volume: 12
Issue: 1
Pages: 4147
•
•
•
•
•
Publication
25099011 | J:216207
First Author: Xie Y
Year: 2014
Journal: Mol Endocrinol
Title: Crosstalk between nuclear MET and SOX9/β-catenin correlates with castration-resistant prostate cancer.
Volume: 28
Issue: 10
Pages: 1629-39
•
•
•
•
•
Publication
29056325 | J:251968
First Author: Malek M
Year: 2017
Journal: Mol Cell
Title: PTEN Regulates PI(3,4)P2 Signaling Downstream of Class I PI3K.
Volume: 68
Issue: 3
Pages: 566-580.e10
•
•
•
•
•
Genotype
Genotype
Symbol: Pten/Pten Trp53/Trp53 Tg(Pbsn-cre)4Prb/?
Background: involves: 129S1/Sv * C57BL/6 * DBA/2
Zygosity: cn
Has Mutant Allele: true
•
•
•
•
•
Genotype
Genotype
Symbol: Rxra/Rxra<+> Tg(Pbsn-cre)4Prb/?
Background: involves: 129S4/SvJae * C57BL/6 * DBA/2
Zygosity: cn
Has Mutant Allele: true
•
•
•
•
•
Genotype
Genotype
Symbol: Rxra/Rxra Tg(Pbsn-cre)4Prb/?
Background: involves: 129S4/SvJae * C57BL/6 * DBA/2
Zygosity: cn
Has Mutant Allele: true
•
•
•
•
•
Genotype
Genotype
Symbol: Gt(ROSA)26Sor/? Tg(Pbsn-cre)4Prb/?
Background: involves: 129X1/SvJ * C57BL/6 * DBA/2
Zygosity: cn
Has Mutant Allele: true
•
•
•
•
•
Genotype
Genotype
Symbol: Pten/Pten Tg(Pbsn-cre)4Prb/?
Background: involves: 129 * 129S4/SvJae * C57BL/6 * DBA/2
Zygosity: cn
Has Mutant Allele: true
•
•
•
•
•
Genotype
Genotype
Symbol: Pik3cb/Pik3cb Tg(Pbsn-cre)4Prb/?
Background: involves: 129 * C57BL/6 * DBA/2
Zygosity: cn
Has Mutant Allele: true
•
•
•
•
•
Genotype
Genotype
Symbol: Pik3ca/Pik3ca Tg(Pbsn-cre)4Prb/?
Background: involves: 129 * C57BL/6 * DBA/2
Zygosity: cn
Has Mutant Allele: true
•
•
•
•
•
Genotype
Genotype
Symbol: Kras/Kras<+> Tg(Pbsn-cre)4Prb/?
Background: involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * DBA/2
Zygosity: cn
Has Mutant Allele: true
•
•
•
•
•
Genotype
Genotype
Symbol: Ctnnb1/Ctnnb1<+> Tg(Pbsn-cre)4Prb/?
Background: involves: 129X1/SvJ * C57BL/6 * DBA/2
Zygosity: cn
Has Mutant Allele: true
•
•
•
•
•
Genotype
Genotype
Symbol: Pten/Pten Tg(Pbsn-cre)4Prb/?
Background: involves: 129S4/SvJae * C57BL/6 * DBA/2
Zygosity: cn
Has Mutant Allele: true
•
•
•
•
•
Genotype
Genotype
Symbol: Pten/Pten<+> Tg(Pbsn-cre)4Prb/?
Background: involves: 129S4/SvJae * BALB/c * C57BL/6 * DBA/2
Zygosity: cn
Has Mutant Allele: true
•
•
•
•
•
Genotype
Genotype
Symbol: Pten/Pten Tg(Pbsn-cre)4Prb/?
Background: involves: 129S4/SvJae * BALB/c * C57BL/6 * DBA/2
Zygosity: cn
Has Mutant Allele: true
•
•
•
•
•
Genotype
Genotype
Symbol: Brca2/Brca2 Tg(Pbsn-cre)4Prb/?
Background: involves: 129P2/OlaHsd * C57BL/6 * DBA/2
Zygosity: cn
Has Mutant Allele: true
•
•
•
•
•
Genotype
Genotype
Symbol: Brca2/Brca2 Trp53/Trp53 Tg(Pbsn-cre)4Prb/?
Background: involves: 129P2/OlaHsd * C57BL/6 * DBA/2
Zygosity: cn
Has Mutant Allele: true
•
•
•
•
•




MouseMine is a collaboration between MGI at The Jackson Laboratory and the InterMine project at the Cambridge Systems Biology Centre. MouseMine is funded through a grant from the NIH/NHGRI.The Jackson Laboratory makes no representation about the suitability or accuracy of this software or data for any purpose, and makes no warranties, either express or implied, including merchantability and fitness for a particular purpose or that the use of this software or data will not infringe any third party patents, copyrights, trademarks, or other rights. the software and data are provided "as is". This software and data are provided to enhance knowledge and encourage progress in the scientific community and are to be used only for research and educational purposes. Any reproduction or use for commercial purpose is prohibited without the prior express written permission of the Jackson Laboratory.

Copyright © 2017 by The Jackson Laboratory. All Rights Reserved

© 2002 - 2017 Department of Genetics, University of Cambridge, Downing Street,
Cambridge CB2 3EH, United Kingdom